Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin
-
Published:2023-02-15
Issue:4
Volume:28
Page:1833
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Albasri Omar Waleed Abduljaleel1, Kumar Palanirajan Vijayaraj1ORCID, Rajagopal Mogana Sundari1ORCID
Affiliation:
1. Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Technology, UCSI University, Jalan Menara Gading, Taman Connaught, Cheras, Kuala Lumpur 56000, Malaysia
Abstract
The oral delivery system is very important and plays a significant role in increasing the solubility of drugs, which eventually will increase their absorption by the digestive system and enhance the drug bioactivity. This study was conducted to synthesize a novel curcumin nano lipid carrier (NLC) and use it as a drug carrier with the help of computational molecular docking to investigate its solubility in different solid and liquid lipids to choose the optimum lipids candidate for the NLCs formulation and avoid the ordinary methods that consume more time, materials, cost, and efforts during laboratory experiments. The antiviral activity of the formed curcumin–NLC against SARS-CoV-2 (COVID-19) was assessed through a molecular docking study of curcumin’s affinity towards the host cell receptors. The novel curcumin drug carrier was synthesized as NLC using a hot and high-pressure homogenization method. Twenty different compositions of the drug carrier (curcumin nano lipid) were synthesized and characterized using different physicochemical techniques such as UV–Vis, FTIR, DSC, XRD, particle size, the zeta potential, and AFM. The in vitro and ex vivo studies were also conducted to test the solubility and the permeability of the 20 curcumin–NLC formulations. The NLC as a drug carrier shows an enormous enhancement in the solubility and permeability of the drug.
Funder
Fundamental Research Grant Scheme Ministry of Higher Education Centre of Excellence in Research, Value Innovation, and Entrepreneurship (CERVIE), UCSI University, Malaysia
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference92 articles.
1. Quintanar-Guerrero, D., Leyva-Gómez, G., Vergara, N.E.M., and Muñoz, N.M. (2022). Nanopharmaceuticals. Nanomater. Nanotechnol. Med., 87–114. 2. Thi, T.T.H., Suys, E.J., Lee, J.S., Nguyen, D.H., Park, K.D., and Truong, N.P. (2021). Lipid-based nanoparticles in the clinic and clinical trials: From cancer nanomedicine to COVID-19 vaccines. Vaccines, 9. 3. A New Approach for β-cyclodextrin Conjugated Drug Delivery System in Cancer Therapy;Sheng;Curr. Drug Deliv.,2022 4. Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active;Sakellari;Food Hydrocoll. Health,2021 5. Li, N., Li, X., Cheng, P., Yang, P., Shi, P., Kong, L., and Liu, H. (2021). Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro. Evid. Based Complement. Altern. Med., 2021.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|